Home Tags RESPECT

Tag: RESPECT

Morphotek Presents Proprietary RESPECT™ ADC Technology at 9th Annual PEGS...

Eisai's subsidiary Morphotek®, a clinical-stage biotechnology company focused on developing novel classes of biological-based products to treat cancer, inflammatory and infectious diseases will present...

PEGG 2017: RESPECT Antibody-drug Conjugate Technology

Earlier this year, a record number of 2,300 delegates attended the 13th edition of the "PEGS: The Essential Protein Engineering Summit," held May 1...

Eisai’s Subsidiary Morphotek Launches ADC Services

Using its proprietary REsidue-SPEcific Conjugation Technology™, also known as  RESPECT™, combined with the company's eribulin-linker toxin platforms, Morphotek, a subsidiary of Eisai, confirmed the...

X